ReviewClinical, cosmetic and investigational dermatology2023

Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing.

Tamara Gracia-Cazaña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.